# Genotropin Study Assessing Use of Injection Pen

> **NCT00965484** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 136 (actual)

## Conditions studied

- Growth Hormone Deficiency
- Idiopathic Short Stature

## Interventions

- **DEVICE:** New Genotropin Pen

## Key facts

- **NCT ID:** NCT00965484
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2011-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965484, "Genotropin Study Assessing Use of Injection Pen". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00965484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*